The role of 1% sodium hyaluronate in anterior capsulotomy with the neodymium:YAG laser in patients with diseased cornea.
Patients with preexisting corneal pathology who needed cataract extraction had an anterior capsulotomy performed with a Q-switched Nd:YAG laser (LASAG Microruptor II). Thirty-two patients had no sodium hyaluronate (Healon) and 36 patients had Healon injected into the anterior chamber prior to the laser surgery. The non-Healon group had a higher incidence of corneal damage from the YAG laser and, as a result, a higher incidence of endothelial corneal decompensation than the patients with the Healon-filled chamber.
D002386:Cataract / Q000150:complications; D002387:Cataract Extraction; D003316:Corneal Diseases / Q000150:complications / Q000601:surgery*; D004341:Drug Evaluation; D006801:Humans; D006820:Hyaluronic Acid / Q000627:therapeutic use*; D007432:Intraoperative Period; D053685:Laser Therapy; D007903:Lens Capsule, Crystalline / Q000601:surgery*; D007908:Lens, Crystalline / Q000601:surgery*; D009994:Osmolar Concentration
D006820:Hyaluronic Acid